Allay Therapeutics
PrivateLast Round
Debt
Jun 5, 2025
Total Funding Raised
$167.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Allay Therapeutics is a biotechnology company that develops sustained analgesic products aimed at enhancing post-surgical pain management and recovery for patients and healthcare providers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allay Therapeutics Comparables
Compare Allay Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Concentric Analgesics | 88% | |
| Cali Biosciences | 85% | |
| Rebel Medicine | 84% | |
Allay Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jun 5, 2025 | ||||
| Series C | Sep 15, 2021 | ||||
| Series B | Feb 12, 2019 |
Allay Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Temasek | Series C |
| Vertex Ventures HC | Debt, Series C |
| Arboretum Ventures | Debt, Series C |
| New Enterprise Associates (NEA) | Debt, Series C, Series B |
| Lightstone Ventures | Series B, Seed, Debt, Series A |
| ClavystBio | Debt |
| EDBI | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 33% MoM, reaching 2.1K.
- Jun 5, 2025
$58M round completed.
Allay Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Allay Therapeutics's valuation, stock price, and market status.